Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
Please note that the ANZCTR website will be unavailable from 9am until 12:30pm (AEDT) on Tuesday 17th November for website maintenance.
Please be sure to log out of the system in order to avoid any loss of data. Thank you and apologies for any inconvenience caused.
A database of clinical trials and their results from Australia, New Zealand, and other countries.
account_circle
Log in
to register or update your trial
search
Search for trials
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT06479135
Registration number
NCT06479135
Ethics application status
Date submitted
21/06/2024
Date registered
28/06/2024
Date last updated
25/09/2025
Titles & IDs
Public title
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Query!
Scientific title
A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Query!
Additional trial identifiers [1]
0
0
KRT-232-115
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
POIESIS
Query!
Related trial records
Query!
Health condition
Health condition(s) studied:
Myelofibrosis
0
0
Query!
Post-PV MF
0
0
Query!
Post-ET Myelofibrosis
0
0
Query!
Primary Myelofibrosis
0
0
Query!
MF
0
0
Query!
Condition category
Condition code
Musculoskeletal
0
0
0
0
Query!
Other muscular and skeletal disorders
Query!
Human Genetics and Inherited Disorders
0
0
0
0
Query!
Other human genetics and inherited disorders
Query!
Cancer
0
0
0
0
Query!
Leukaemia - Chronic leukaemia
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of the intervention or exposure
Treatment: Drugs - Navtemadlin
Treatment: Drugs - Navtemadlin placebo
Treatment: Drugs - Ruxolitinib
Experimental: Arm 1 - Navtemadlin administered orally once daily on Days 1-7, off treatment on Days 8-28, in 28-day treatment cycles. Ruxolitinib administered orally twice a day.
Active comparator: Arm 2 - Navtemadlin placebo administered orally once daily on Days 1-7, off treatment on Days 8-28, in 28-day treatment cycles. Ruxolitinib administered orally twice a day.
Treatment: Drugs: Navtemadlin
Navtemadlin is an investigational MDM2 inhibitor
Treatment: Drugs: Navtemadlin placebo
Navtemadlin placebo
Treatment: Drugs: Ruxolitinib
Ruxolitinib is a janus kinase 1/2 inhibitor
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Description of the comparator or control
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
To compare spleen volume reduction (SVR35) between Arm 1 and Arm 2
Query!
Assessment method [1]
0
0
The proportion of subjects in each arm with SVR35 by MRI/CT scan (central review) 24 weeks after start of the randomized period
Query!
Timepoint [1]
0
0
24 weeks
Query!
Primary outcome [2]
0
0
To compare total symptom score reduction (TSS50) between Arm 1 and Arm 2
Query!
Assessment method [2]
0
0
The proportion of subjects in each arm with a TSS50 by the Myelofibrosis Symptom Assessment Form (MFSAF) v4.0 24 weeks after start of the randomized period
Query!
Timepoint [2]
0
0
24 weeks
Query!
Secondary outcome [1]
0
0
To compare time to progression between Arm 1 and Arm 2
Query!
Assessment method [1]
0
0
Time to progression or death from any cause in subjects randomized to each arm
Query!
Timepoint [1]
0
0
Up to 8 years
Query!
Secondary outcome [2]
0
0
To compare overall survival (OS) between Arm 1 and Arm 2
Query!
Assessment method [2]
0
0
Time to death from any cause in subjects randomized to each arm
Query!
Timepoint [2]
0
0
Up to 8 years
Query!
Eligibility
Key inclusion criteria
Inclusion Criteria for Ruxolitinib Alone Period:
* Confirmed diagnosis of PMF, post-PV MF, or post-ET MF, as assessed by the treating physician according to the World Health Organization (WHO) criteria
* High, Intermediate-1, Intermediate-2 risk category International Prognosis System Score (IPSS)
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
* JAK-inhibitor treatment naive
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Healthy volunteers
No
Query!
Key exclusion criteria
Exclusion Criteria for Ruxolitinib Alone Period:
* Prior Splenectomy
* Splenic irradiation within 3 months prior to the first dose
* Prior BCL-XL, BET, MDM2, PI3K, PIM, or XPO1 inhibitors therapy or p53-directed therapy
* Eligible for Bone Marrow Transplant
* Peripheral blood or bone marrow blast count = 10 percent
Inclusion Criteria for Randomized Period:
* PMF, post-PV MF, or post-ET MF that is TP53WT as assessed by central testing
* ECOG performance status of 0 to 2
* Treatment with a stable dose of ruxolitinib
* Suboptimal response to run-in ruxolitinib treatment
Exclusion Criteria for Randomized Period:
* Elevated white blood cell count that doubles (or more) during ruxolitinib treatment and exceeds 50 × 10^9/L
* Peripheral blood or bone marrow blast count = 10 percent
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
3/06/2024
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
31/12/2028
Query!
Actual
Query!
Sample size
Target
600
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
TAS,WA
Query!
Recruitment hospital [1]
0
0
Royal Hobart Hospital (RHH) - Hobart
Query!
Recruitment hospital [2]
0
0
Sir Charles Gairdner Hospital - Nedlands
Query!
Recruitment hospital [3]
0
0
Royal Adelaide Hospital - Adelaide
Query!
Recruitment hospital [4]
0
0
Monash Medical Center Clayton - Clayton
Query!
Recruitment hospital [5]
0
0
Townsville University Hospital - Douglas
Query!
Recruitment hospital [6]
0
0
Gosford Hospital - Gosford
Query!
Recruitment hospital [7]
0
0
St George Hospital - Kogarah
Query!
Recruitment hospital [8]
0
0
The Royal Melbourne Hospital - Peter MacCallum Cancer Center - Melbourne
Query!
Recruitment hospital [9]
0
0
The Alfred Hospital - Melbourne
Query!
Recruitment hospital [10]
0
0
Royal Perth Hospital - Perth
Query!
Recruitment hospital [11]
0
0
Calvary Mater Newcastle Hospital - Waratah
Query!
Recruitment postcode(s) [1]
0
0
7000 - Hobart
Query!
Recruitment postcode(s) [2]
0
0
6009 - Nedlands
Query!
Recruitment postcode(s) [3]
0
0
SA 5000 - Adelaide
Query!
Recruitment postcode(s) [4]
0
0
VIC 3168 - Clayton
Query!
Recruitment postcode(s) [5]
0
0
QLD 4814 - Douglas
Query!
Recruitment postcode(s) [6]
0
0
NSW 2250 - Gosford
Query!
Recruitment postcode(s) [7]
0
0
NSW 2217 - Kogarah
Query!
Recruitment postcode(s) [8]
0
0
VIC 3000 - Melbourne
Query!
Recruitment postcode(s) [9]
0
0
VIC 3004 - Melbourne
Query!
Recruitment postcode(s) [10]
0
0
6000 - Perth
Query!
Recruitment postcode(s) [11]
0
0
NSW 2298 - Waratah
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Alabama
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Arizona
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
California
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
Colorado
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Delaware
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
District of Columbia
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Florida
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Iowa
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Kansas
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Kentucky
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Louisiana
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Maryland
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Massachusetts
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Michigan
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
Nebraska
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
Nevada
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
New Jersey
Query!
Country [18]
0
0
United States of America
Query!
State/province [18]
0
0
New York
Query!
Country [19]
0
0
United States of America
Query!
State/province [19]
0
0
North Carolina
Query!
Country [20]
0
0
United States of America
Query!
State/province [20]
0
0
Ohio
Query!
Country [21]
0
0
United States of America
Query!
State/province [21]
0
0
Oregon
Query!
Country [22]
0
0
United States of America
Query!
State/province [22]
0
0
Pennsylvania
Query!
Country [23]
0
0
United States of America
Query!
State/province [23]
0
0
Tennessee
Query!
Country [24]
0
0
United States of America
Query!
State/province [24]
0
0
Texas
Query!
Country [25]
0
0
United States of America
Query!
State/province [25]
0
0
Utah
Query!
Country [26]
0
0
United States of America
Query!
State/province [26]
0
0
Virginia
Query!
Country [27]
0
0
United States of America
Query!
State/province [27]
0
0
Washington
Query!
Country [28]
0
0
United States of America
Query!
State/province [28]
0
0
Wisconsin
Query!
Country [29]
0
0
Austria
Query!
State/province [29]
0
0
Graz
Query!
Country [30]
0
0
Austria
Query!
State/province [30]
0
0
Innsbruck
Query!
Country [31]
0
0
Austria
Query!
State/province [31]
0
0
Leoben
Query!
Country [32]
0
0
Austria
Query!
State/province [32]
0
0
Linz
Query!
Country [33]
0
0
Austria
Query!
State/province [33]
0
0
Vienna
Query!
Country [34]
0
0
Belgium
Query!
State/province [34]
0
0
Antwerp
Query!
Country [35]
0
0
Belgium
Query!
State/province [35]
0
0
Leuven
Query!
Country [36]
0
0
Belgium
Query!
State/province [36]
0
0
Liège
Query!
Country [37]
0
0
Belgium
Query!
State/province [37]
0
0
Roeselare
Query!
Country [38]
0
0
Belgium
Query!
State/province [38]
0
0
Yvoir
Query!
Country [39]
0
0
Croatia
Query!
State/province [39]
0
0
Rijeka
Query!
Country [40]
0
0
Croatia
Query!
State/province [40]
0
0
Split
Query!
Country [41]
0
0
Croatia
Query!
State/province [41]
0
0
Šibenik
Query!
Country [42]
0
0
Croatia
Query!
State/province [42]
0
0
Zagreb
Query!
Country [43]
0
0
Czechia
Query!
State/province [43]
0
0
Brno
Query!
Country [44]
0
0
Czechia
Query!
State/province [44]
0
0
Hradec Králové
Query!
Country [45]
0
0
Czechia
Query!
State/province [45]
0
0
Ostrava
Query!
Country [46]
0
0
Czechia
Query!
State/province [46]
0
0
Prague
Query!
Country [47]
0
0
France
Query!
State/province [47]
0
0
Paris
Query!
Country [48]
0
0
France
Query!
State/province [48]
0
0
Amiens
Query!
Country [49]
0
0
France
Query!
State/province [49]
0
0
Angers
Query!
Country [50]
0
0
France
Query!
State/province [50]
0
0
Lille
Query!
Country [51]
0
0
France
Query!
State/province [51]
0
0
Lyon
Query!
Country [52]
0
0
France
Query!
State/province [52]
0
0
Nantes
Query!
Country [53]
0
0
France
Query!
State/province [53]
0
0
Nice
Query!
Country [54]
0
0
France
Query!
State/province [54]
0
0
Nîmes
Query!
Country [55]
0
0
France
Query!
State/province [55]
0
0
Pessac
Query!
Country [56]
0
0
France
Query!
State/province [56]
0
0
Poitiers
Query!
Country [57]
0
0
France
Query!
State/province [57]
0
0
Strasbourg
Query!
Country [58]
0
0
France
Query!
State/province [58]
0
0
Toulouse
Query!
Country [59]
0
0
France
Query!
State/province [59]
0
0
Tours
Query!
Country [60]
0
0
Georgia
Query!
State/province [60]
0
0
Kutaisi
Query!
Country [61]
0
0
Georgia
Query!
State/province [61]
0
0
Tbilisi
Query!
Country [62]
0
0
Germany
Query!
State/province [62]
0
0
Düsseldorf
Query!
Country [63]
0
0
Germany
Query!
State/province [63]
0
0
Freiburg im Breisgau
Query!
Country [64]
0
0
Germany
Query!
State/province [64]
0
0
Halle
Query!
Country [65]
0
0
Germany
Query!
State/province [65]
0
0
Hamburg
Query!
Country [66]
0
0
Germany
Query!
State/province [66]
0
0
Hanover
Query!
Country [67]
0
0
Germany
Query!
State/province [67]
0
0
Heidelberg
Query!
Country [68]
0
0
Germany
Query!
State/province [68]
0
0
Jena
Query!
Country [69]
0
0
Germany
Query!
State/province [69]
0
0
Kiel
Query!
Country [70]
0
0
Germany
Query!
State/province [70]
0
0
Leipzig
Query!
Country [71]
0
0
Germany
Query!
State/province [71]
0
0
Munich
Query!
Country [72]
0
0
Germany
Query!
State/province [72]
0
0
Mutlangen
Query!
Country [73]
0
0
Germany
Query!
State/province [73]
0
0
Nuremberg
Query!
Country [74]
0
0
Germany
Query!
State/province [74]
0
0
Stuttgart
Query!
Country [75]
0
0
Germany
Query!
State/province [75]
0
0
Ulm
Query!
Country [76]
0
0
Greece
Query!
State/province [76]
0
0
Athens
Query!
Country [77]
0
0
Greece
Query!
State/province [77]
0
0
Ioannina
Query!
Country [78]
0
0
Greece
Query!
State/province [78]
0
0
Pátrai
Query!
Country [79]
0
0
Greece
Query!
State/province [79]
0
0
Thessaloniki
Query!
Country [80]
0
0
Hungary
Query!
State/province [80]
0
0
Budapest
Query!
Country [81]
0
0
Hungary
Query!
State/province [81]
0
0
Nyíregyháza
Query!
Country [82]
0
0
Hungary
Query!
State/province [82]
0
0
Szekszárd
Query!
Country [83]
0
0
Hungary
Query!
State/province [83]
0
0
Székesfehérvár
Query!
Country [84]
0
0
Italy
Query!
State/province [84]
0
0
Alessandria
Query!
Country [85]
0
0
Italy
Query!
State/province [85]
0
0
Ancona
Query!
Country [86]
0
0
Italy
Query!
State/province [86]
0
0
Bologna
Query!
Country [87]
0
0
Italy
Query!
State/province [87]
0
0
Brescia
Query!
Country [88]
0
0
Italy
Query!
State/province [88]
0
0
Catania
Query!
Country [89]
0
0
Italy
Query!
State/province [89]
0
0
Florence
Query!
Country [90]
0
0
Italy
Query!
State/province [90]
0
0
Forlì
Query!
Country [91]
0
0
Italy
Query!
State/province [91]
0
0
Milan
Query!
Country [92]
0
0
Italy
Query!
State/province [92]
0
0
Novara
Query!
Country [93]
0
0
Italy
Query!
State/province [93]
0
0
Orbassano
Query!
Country [94]
0
0
Italy
Query!
State/province [94]
0
0
Palermo
Query!
Country [95]
0
0
Italy
Query!
State/province [95]
0
0
Pavia
Query!
Country [96]
0
0
Italy
Query!
State/province [96]
0
0
Pesaro
Query!
Country [97]
0
0
Italy
Query!
State/province [97]
0
0
Reggio Emilia
Query!
Country [98]
0
0
Italy
Query!
State/province [98]
0
0
Rome
Query!
Country [99]
0
0
Italy
Query!
State/province [99]
0
0
Turin
Query!
Country [100]
0
0
Italy
Query!
State/province [100]
0
0
Varese
Query!
Country [101]
0
0
Poland
Query!
State/province [101]
0
0
Bialystok
Query!
Country [102]
0
0
Poland
Query!
State/province [102]
0
0
Gdansk
Query!
Country [103]
0
0
Poland
Query!
State/province [103]
0
0
Krakow
Query!
Country [104]
0
0
Poland
Query!
State/province [104]
0
0
Lodz
Query!
Country [105]
0
0
Poland
Query!
State/province [105]
0
0
Nowy Sacz
Query!
Country [106]
0
0
Poland
Query!
State/province [106]
0
0
Olsztyn
Query!
Country [107]
0
0
Poland
Query!
State/province [107]
0
0
Poznan
Query!
Country [108]
0
0
Poland
Query!
State/province [108]
0
0
Szczecin
Query!
Country [109]
0
0
Poland
Query!
State/province [109]
0
0
Slupsk
Query!
Country [110]
0
0
Poland
Query!
State/province [110]
0
0
Warsaw
Query!
Country [111]
0
0
Poland
Query!
State/province [111]
0
0
Walbrzych
Query!
Country [112]
0
0
Poland
Query!
State/province [112]
0
0
Wroclaw
Query!
Country [113]
0
0
Portugal
Query!
State/province [113]
0
0
Aveiro
Query!
Country [114]
0
0
Portugal
Query!
State/province [114]
0
0
Braga
Query!
Country [115]
0
0
Portugal
Query!
State/province [115]
0
0
Lisbon
Query!
Country [116]
0
0
Portugal
Query!
State/province [116]
0
0
Vila Nova de Gaia
Query!
Country [117]
0
0
Romania
Query!
State/province [117]
0
0
Brasov
Query!
Country [118]
0
0
Romania
Query!
State/province [118]
0
0
Bucharest
Query!
Country [119]
0
0
Romania
Query!
State/province [119]
0
0
Cluj-Napoca
Query!
Country [120]
0
0
Romania
Query!
State/province [120]
0
0
Oradea
Query!
Country [121]
0
0
Romania
Query!
State/province [121]
0
0
Târgu Mures
Query!
Country [122]
0
0
Serbia
Query!
State/province [122]
0
0
Belgrade
Query!
Country [123]
0
0
Serbia
Query!
State/province [123]
0
0
Kragujevac
Query!
Country [124]
0
0
Serbia
Query!
State/province [124]
0
0
Novi Sad
Query!
Country [125]
0
0
South Korea
Query!
State/province [125]
0
0
Busan
Query!
Country [126]
0
0
South Korea
Query!
State/province [126]
0
0
Daegu
Query!
Country [127]
0
0
South Korea
Query!
State/province [127]
0
0
Seoul
Query!
Country [128]
0
0
Spain
Query!
State/province [128]
0
0
Badalona
Query!
Country [129]
0
0
Spain
Query!
State/province [129]
0
0
Barcelona
Query!
Country [130]
0
0
Spain
Query!
State/province [130]
0
0
Cáceres
Query!
Country [131]
0
0
Spain
Query!
State/province [131]
0
0
Las Palmas de Gran Canaria
Query!
Country [132]
0
0
Spain
Query!
State/province [132]
0
0
Madrid
Query!
Country [133]
0
0
Spain
Query!
State/province [133]
0
0
Málaga
Query!
Country [134]
0
0
Spain
Query!
State/province [134]
0
0
Salamanca
Query!
Country [135]
0
0
Spain
Query!
State/province [135]
0
0
Valencia
Query!
Country [136]
0
0
Spain
Query!
State/province [136]
0
0
Zaragoza
Query!
Country [137]
0
0
United Kingdom
Query!
State/province [137]
0
0
Birmingham
Query!
Country [138]
0
0
United Kingdom
Query!
State/province [138]
0
0
Boston
Query!
Country [139]
0
0
United Kingdom
Query!
State/province [139]
0
0
Cambridge
Query!
Country [140]
0
0
United Kingdom
Query!
State/province [140]
0
0
Cardiff
Query!
Country [141]
0
0
United Kingdom
Query!
State/province [141]
0
0
Edinburgh
Query!
Country [142]
0
0
United Kingdom
Query!
State/province [142]
0
0
Gloucester
Query!
Country [143]
0
0
United Kingdom
Query!
State/province [143]
0
0
Harrogate
Query!
Country [144]
0
0
United Kingdom
Query!
State/province [144]
0
0
Leicester
Query!
Country [145]
0
0
United Kingdom
Query!
State/province [145]
0
0
Liverpool
Query!
Country [146]
0
0
United Kingdom
Query!
State/province [146]
0
0
London
Query!
Country [147]
0
0
United Kingdom
Query!
State/province [147]
0
0
Oxford
Query!
Country [148]
0
0
United Kingdom
Query!
State/province [148]
0
0
Windsor
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Kartos Therapeutics, Inc.
Query!
Address
Query!
Country
Query!
Secondary sponsor
Nil
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This clinical trial is evaluating whether addition of navtemadlin to ruxolitinib treatment will provide more clinical benefit than ruxolitinib alone for patients with Myelofibrosis who have a suboptimal response to ruxolitinib treatment alone. Subjects will start by receiving ruxolitinib alone in the run-in period. Those who demostrate a suboptimal response from ruxolitinib alone will then be randomized 2:1 to receive navtemadlin or navtemadlin placebo as add-on treatment to their ongoing ruxolitinib. Randomized means that subjects will be assigned to a group by chance, like a flip of a coin. The study is blinded, meaning the subjects, doctors, central endpoint assessors and sponsor will not know which add on treatment (navtemadlin or navtemadlin placebo) the subject is receiving.
Query!
Trial website
https://clinicaltrials.gov/study/NCT06479135
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
John Mei
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
650-542-0136
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT06479135
Download to PDF